A b s t r a c t
In-depth study of cell cycle proteins and human papillomavirus (HPV) genotyping can provide useful information about the malignant potential of precursor lesions of cervical carcinoma (CC). Immunostaining of cell cycle-related proteins (p16, cyclin D1, Ki-67, p53, and ProEx C) was evaluated using tissue microarrays, and HPV genotypes were identified in 144 cervical tissue specimens encompassing normal or benign epithelial lesions, low-and high-grade squamous intraepithelial lesions (LSIL and HSIL, respectively), and CC. In addition, 14 cases with atypical immature metaplasia (AIM) were included to compare their immunohistochemical features with those of wellestablished precursor lesions. Expression of p16, Ki-67, and ProEx C was most associated with the severity of dysplasia. Positive expression of p16, Ki-67, and ProEx C and negative expression of p53 seem to be related to HPV-16 infection. AIM cases show an immunohistochemical pattern more similar to LSIL than to HSIL. Immunohistochemical assessment of cell cycle proteins may help to distinguish normal and benign conditions of the cervix from precursor lesions of CC.
Unscheduled cell cycle activation constitutes a crucial process in virtually all human cancers. The human papillomavirus (HPV) infection is the leading cause of carcinoma of the uterine cervix, and HPV DNA is found in more that 95% of the cases of this type of cancer, the second most common cancer in women worldwide, with an incidence of 371,000 new cases and a mortality of 190,000 females per year. 1 Through the expression of E7 and E6 viral oncoproteins, certain HPV genotypes (high-risk HPV) block pRb and p53 cellular proteins and, thus, generate a state of unscheduled activation of the cell cycle and create a permissive state for the appearance of nonrepairing novel mutations and genomic instability. Functional alteration of cell cycle regulators in cervical cancer is, therefore, paradigmatic and seems to have a major role in cervical cancer pathogenesis. Much effort has been expended in attempts to clarify the role of cell cycle regulators in the progression of squamous intraepithelial lesions (SILs) to cervical cancer. In addition to p53 and pRb as targets of E6 and E7 HPV oncoproteins, cyclins such as cyclin D1 and cyclin inhibitors such as p16 are key proteins in the study of the molecular alterations that characterize cervical carcinoma.
p16 is a tumor suppressor protein belonging to the family of INK4 cyclin-dependent-kinase inhibitors whose increased expression has been associated with HPV-infected dysplastic and neoplastic epithelium of the cervix. It has been hypothesized that this expression is the result of the negative feedback induced by p16 on functional inactivation of pRb by Upon completion of this activity you will be able to:
• define the role of human papillomavirus-induced alterations on cell cycle proteins in cervical carcinogenesis.
• apply information provided by immunohistochemistry markers for the correct diagnosis of precursor lesions of cervical carcinoma.
• discuss the possible oncogenic potential of atypical immature metaplasia.
The ASCP is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASCP designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit ™ per article. This activity qualifies as an American Boardimmunostaining pattern of the cell cycle regulators p16, cyclin D1, Ki-67, p53, and ProEx C and their relationship with the histologic grade of precursor lesions of cervical carcinoma in a cohort of females from Southeast Spain; (2) to assess the relationships between the expression of these 5 markers in cervical benign conditions and SIL; (3) to evaluate the association between the immunohistochemical expression of these 5 proteins and HPV genotypes; and (4) to characterize the HPV genotype and the immunohistochemical pattern of AIM lesions for p16, cyclin D1, Ki-67, p53, and ProEx C and compare them with those found in well-established precursor lesions (LSIL and HSIL). Given the considerable number of cases and immunohistochemical markers evaluated, we decided to carry out this study on tissue microarrays (TMAs) to gain a possible increase in staining homogeneity. Recently, the application of this technology has been shown to be a useful and reliable tool for the study of cervical cancer and its precursor lesions. 3, 12, 21 
Materials and Methods

Tissue Samples
We used 169 paraffin blocks (cases) obtained from conization and hysterectomy specimens in this study. Specimens were collected from 2 hospitals from the Murcia Region located in a coastal area of southeastern Spain: Santa María del Rosell University Hospital and Virgen de la Arrixaca University Hospital. All identifiers were deleted to protect patient confidentiality, and the study was approved by the local ethical board.
Tissue specimens had been routinely fixed in 4% formaldehyde and embedded in paraffin. Paraffin blocks were cut in 4-μm sections and stained with H&E. Freshly stained histologic sections of each paraffin block were reviewed by 1 pathologist (S.O.-R.) trained for and in charge of gynecologic pathology at Santa María del Rosell University Hospital. With a marking pen, the same pathologist circled the normal or benign squamous areas and the specific zones harboring SIL or carcinoma, and these zones were subsequently punched out for the construction of 3 TMAs. After a TMA quality control (see "TMA Block Construction"), 150 cases were suitable for review. TMAs were made up of 31 normal or benign cervices (N/B; 23 normal, 2 squamous metaplasia; and 6 cervicitis), 21 LSIL, 93 HSIL, and 5 cervical invasive carcinomas (4 squamous cervical carcinomas and 1 cervical adenocarcinoma). An additional set of 14 AIMs was included. Histologic classification was done according to World Health Organization criteria in which LSIL comprises condyloma and cervical intraepithelial neoplasia (CIN) grade 1 and HSIL includes CIN 2 and CIN 3. 9 AIM cases were diagnosed according to histologic criteria published elsewhere. 18 Control samples of N/B were taken from female patients who underwent total hysterectomy because of uterine leiomyomas.
TMA Block Construction
The areas ink marked by the reviewing pathologist were included in 3 TMAs. Owing to the limited extension of SIL, 2 cores were included for each case, as described elsewhere. 22 Each core tissue measured 1 mm in diameter. TMAs were manufactured using the manual tissue microarrayer, MTA1 (Beecher Instruments, Sun Prairie, WI). Three paraffin-block TMAs were made and 4-μm step-sectioned. Consecutive histologic sections were mounted on slides treated with electrostatic charges and air dried at 60°C for 20 minutes or at 37°C for 12 hours. H&E staining was performed in the first and last sections of each TMA to check the quality of the cores included in the 3 TMAs.
H&E-stained sections of TMAs were reviewed in a double-blinded manner by 2 pathologists (S.O.-R. and J.A.-O.), and the histologic diagnoses were exported into an Excel (Microsoft, Redmond, WA) file for statistical evaluation of the data.
Immunohistochemical Analysis
Tissue slides were deparaffinized, and antigen retrieval was carried out by treating the sections with Target Retrieval Solution, pH 6.0 (S1699, DAKO, Copenhagen, Denmark) using PTLink (DAKO). The tissues were then washed 3 times with tris(hydroxymethyl)aminomethane buffer solution, pH 7.6, containing Tween 20 (S3006, DAKO). Sections were incubated with primary antibodies to human p53 (catalog No. NCLp53-DO7, Novocastra, Newcastle upon Tyne, England); ProEx C (clone MCM2 26H6.19, MCM2 27C5.6, TOP2A SWT3D1, Tripath Imaging, Burlington, NC); and cyclin D1 (catalog No. M7155), Ki-67 (catalog No. M7240), and p16 (K5334) from DAKO. The dilution of each antibody was based on the manufacturer's instructions. Treatment of 3% hydrogen peroxide in water for 5 minutes was applied for endogenous peroxidase blocking. The EnVision (DAKO) polymer-based system was used for antigen detection. As positive and negative control samples, a section of an HSIL and a normal cervix sample were used, as done by Shi et al. 15 Reagent negative control experiments were performed by omitting the primary antibody and replacing it with DAKO REAL antibody diluent (S2022, DAKO). Slides were counterstained with H&E, washed, and mounted with DPX (VWR International, Poole, England).
Immunohistochemical interpretation for all specimens was performed in a blinded manner by one of us (M.P.-G.). Immunostaining of all sections was evaluated for positive or negative staining; stained cellular compartment (membrane, cytoplasm, or nucleus); and cell-layer level of expression: parabasal layer, pb+; lower third of the epithelium, 1+; lower two thirds, 2+; and more than the lower two thirds up to full thickness, 3+. Finally, a diffuse pattern was defined as immunostaining in more than 50% of dysplastic squamous epithelium and a focal pattern as immunostaining in less than 50% of dysplastic squamous epithelium as proposed by Shi et al. 15 Samples with immunostaining restricted to only basal and parabasal cell layers were considered negative for these markers, as reported by Badr et al 16 and Qiao et al 23 for ProEx C and Ki-67. Positive vs negative staining, the stained cellular compartment, a diffuse pattern, and a focal pattern were scored separately in each TMA and input into an Excel file for statistical analysis.
When immunohistochemical findings were in disagreement between the two cores obtained from the same sample, the higher score was selected. Microphotographs were taken with a light microscope (Leica DMD108, Leica Microsystems, Wetzlar, Germany).
DNA Extraction
Areas selected by the reviewing pathologist were cut in 4-μm sections from the original paraffin blocks. A brand-new microtome blade was used for step-sectioning each paraffin block to avoid HPV cross-contamination. Genomic DNA extraction was performed using the GeneAll kit (General Biosystems, Seoul, Korea) according to the instruction manual. DNA was resuspended in 100 μL of water and frozen.
HPV Genotyping
Viral genotyping was performed using the Hybribio HPV genoarray kit (Hybribio, Hong Kong, China) in accordance with the manufacturer's instructions. Amplification of the L1 conserved region with biotin-labeled primers was performed, and amplicons were denaturized and subjected to flow-through hybridization on a low-density array consisting of a nylon 6,6 biodyne membrane coated with 21 HPV type-specific probes corresponding to the high-risk genotypes 16, 18, 31, 33, 35, 39, 45 , 51, 52, 56, 58, 59, 66, and 68; low-risk genotypes 6, 11, 42, 43, and 44; and genotypes with undetermined risk, such as 53 and CP8340. Nonbound amplicons and excess reagents were washed away with a vacuum pump. Membrane was incubated with streptavidin-alkaline phosphatase conjugate and treated with nitroblue tetrazolium substrate. Color development indicated presence of the corresponding HPV genotype. A hybridization positive control containing biotin, a polymerase chain reaction internal control, and HPV-and HPV+ (HPV18) controls were included.
Statistical Analysis
Data statistical analysis was performed using SPSS, version 14.0 (SPSS, Chicago, IL). Sample variability between peer cores was evaluated by using the McNemar test, and the κ statistic was used to assess the interobserver concordance. χ 2 was used to calculate statistical significance; a P value less than .05 was considered statistically significant.
Results
TMA Validation
Of 169 cases, 150 (88.8%) were suitable for evaluation. Concordance of pathologic diagnoses between the 2 observers was 85.7% (κ coefficient; 95% CI, 72.0%-99.3%). Sample variability between the 2 cores from the same specimen was calculated by the McNemar index, which revealed that this variability was 16% or less for both histologic diagnoses (McNemar index, 7.2; P = .12) and for positive or negative expression of all immunohistochemical markers. Markers in order of increasing reproducibility between peer cores were cyclin D1, p53, p16, Ki-67, and ProEx C.
Expression of p16, Cyclin D1, Ki-67, p53, and ProEx C and Their Relationship to Histologic Grade
Immunohistochemical expression of p16, cyclin D1, Ki-67, p53, and ProEx C was observed in 132, 136, 132, 136, and 124 cases, respectively. ❚Table 1❚ lists the expression of these 5 antibodies and their relationship to histologic diagnoses.
Expression of p16 was detected in 4 (14%) of 28 N/B cases, 12 (63%) of 19 LSIL cases, and 70 (88%) of HSIL cases (P < .001) ❚Table 2❚, ❚Image 1A❚, ❚Image 1B❚, and ❚Im-age 1C❚. p16 expression showed a diffuse pattern in all cases. When expressed, p16 staining was localized in the nucleus and/or the cytoplasm. The p16+ cases showed predominant cytoplasmic expression in 0 (0%) of 4, 1 (8%) of 12, and 14 (20%) of 70 N/B, LSIL, and HSIL cases, respectively (P > .05; Table 1 ) ❚Image 2A❚ and ❚Image 2B❚. Expression restricted to the lower third (1+) of the epithelium was observed in 16 (18%) of 90 positive cases, whereas 2+ and 3+ staining were seen in 35 (39%) and 39 (43%), respectively. Predominance of nuclear or cytoplasmic staining was seen in 58 (64%) and 16 (18%) of 90 cases, respectively (Table 1) . 1+, 2+, and 3+ staining were observed in 2 (13%), 5 (31%), and 9 (56%) of 16 cases showing cytoplasmic predominance (P > .05).
Aberrant expression of cyclin D1 was detected in 25 (86%) of 29 N/B cases, 19 (90%) of 21 LSIL cases, and 79 (98%) of 81 HSIL cases (P > .05) ❚Image 1D❚, ❚Image 1E❚, and ❚Image 1F❚. All 5 carcinoma cases were positive for cyclin D1 expression (Table 2) . When considering expression in the lower third as negative, cyclin D1 was positive in 9 (31%) of 29 N/B, 11 (52%) of 21 LSIL, and 73 (90%) of 81 HSIL cases (P < .05). When expressed, cyclin D1 showed a diffuse pattern of staining in all cases. Cyclin D1 was expressed in the cytoplasmic and nuclear compartments. Predominance of cytoplasmic expression was seen in 7 (28%) of 25 N/B cases, 10 (53%) of LSIL cases, 67 (85%) of 79 HSIL cases, and 5 (100%) of 5 carcinoma cases (P < .05; Table 1 ) ❚Image 2C❚ and ❚Image 2D❚. Immunostaining of 1+, 2+, and 3+ was observed in 23.4%, 24.2%, and 52.3%, respectively, of the 128 cases. Predominance of nuclear or cytoplasmic immunostaining was observed in 18.8% and 69.5% of positive cases (Table 1) ; 1+, 2+, and 3+ staining was seen in 4 (4%), 21 (24%), and 64 (72%), respectively, of 89 cases showing cytoplasmic predominance (P < .05).
Positive Ki-67 expression was detected in 6 (23%) of 26 N/B cases, 10 (48%) of 21 LSIL cases, and 72 (89%) of 81 HSIL cases (P < .05; Table 2 ) ❚Image 1G❚, ❚Image 1H❚, and ❚Image 1I❚. All carcinoma cases were positive for Ki-67. Thirty-two cases (24%) showed pb+ expression and were considered negative. Diffuse staining was seen in 1 (17%) of 6 positive N/B cases, 5 (50%) of 10 positive LSIL cases, and 54 (75%) of 72 positive HSIL cases (P < .05; Table 1 ). Ki-67 was expressed exclusively in the nuclear compartment in all cases. Immunostaining of 1+, 2+, and 3+ was observed in 1 (1%), 38 (41%), and 53 (58%) of 92 positive cases, respectively. Ki-67 showed a diffuse pattern in 62 (67%) of 92 positive cases ( Table 1) . Staining of 1+, 2+, and 3+ was seen in 0 (0%), 20 (32%), and 42 (68%), respectively, of cases showing a diffuse pattern (P < .05).
Expression of p53 was detected in 18 (62%) of 29 N/B cases, 11 (55%) of 20 LSIL cases, and 44 (54%) of 82 HSIL cases (P > .05; Table 2 ) ❚Image 1J❚, ❚Image 1K❚, and ❚Image 1L❚. p53 showed a diffuse pattern of expression in 12 (67%) of 18 N/B cases, 4 (36%) of 11 LSIL cases, and 11 (25%) of 44 HSIL cases (P = .07; Table 1 ). Immunostaining for p53 showed nuclear localization in all cases. Immunostaining of 1+, 2+, and 3+ was seen in 39 (52%), 18 (24%), and 18 (24%), respectively, of 75 cases. p53 staining displayed a focal pattern in 46 (61%) of 75 positive cases ( Table 1 ). The focal pattern was associated with an increasing cell-layer level of immunostaining: 1+, 12 (31%); 2+, 17 (94%); and 3+, 17 (94%) (P < .05).
Positive ProEx C expression was detected in 3 (12%) of 26 N/B cases, 10 (53%) of 19 LSIL cases, and 65 (87%) of 75 HSIL cases (P < .05; Table 2 ) ❚Image 1M❚, ❚Image 1N❚, and ❚Image 1O❚. ProEx C was detected throughout the epithelium (3+ staining) in all carcinoma cases. A diffuse pattern of ProEx C expression was reported in 2 (67%) of 3 N/B cases, 10 (100%) of 10 LSIL cases, 56 (86%) of 65 HSIL cases (P < .05), and 5 (100%) of 5 carcinomas (Table 1 ). ProEx C localization was nuclear in all cases. All negative cases showed pb+ staining. Immunostaining of 1+, 2+, and 3+ was observed in 8 (10%), 40 (48%), and 35 (42%), respectively, of 83 cases. A diffuse pattern was seen in 42% of cases showing pb+ staining and in 73 (88%) of 83 positive cases (Table 1 ) and was AIM, atypical immature metaplasia; HPV, human papillomavirus; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; N, not significant; N/B, normal/benign cervical epithelium; Y, significant; Y † , significant when considering as negative the expression in the lower one third of the epithelium. * Data are given as number/total (percentage). Significance analysis was performed for N/B, LSIL, and HSIL, and significance was set at P > .05.
Image 1
Immunohistochemical evaluation of p16, cyclin D1, Ki-67, p53, and ProEx C in normal/ benign exocervix (N/B), low-grade squamous intraepithelial lesion (LSIL), and high-grade squamous intraepithelial lesion (HSIL). A, Absence of staining. B, 1+ distribution, diffuse pattern, and nuclear-predominant staining (NP) localization. C, 3+ distribution, diffuse pattern, and nuclear and cytoplasmic staining (N/C) localization. D, pb+ distribution, diffuse pattern, and NP localization. E, 1+ distribution, diffuse pattern, and cytoplasmicpredominant staining (CP) localization. F, 3+ distribution, diffuse pattern, and CP localization. G, pb+ distribution, focal pattern, and nuclear localization. H, 2+ distribution, focal pattern, and nuclear localization. I, 3+ distribution, focal pattern, and nuclear localization. J, Absence of staining. K, pb+ distribution, diffuse pattern, and nuclear localization. L, 3+ distribution, focal pattern, and nuclear localization. M, pb+ distribution, diffuse pattern, and nuclear localization. N, 2+ distribution, diffuse pattern, and nuclear localization. O, 3+ distribution, diffuse pattern, and nuclear localization (A-O, H&E counterstain, ×100). Staining distribution was scored as follows: pb+, basal 1-2 layers; 1+, lower one third of the epithelium; 2+, lower two thirds; 3+, more than the lower two thirds up to full thickness.
with cyclin D1 staining (P < .05). No significant association was found between cyclin D1 and p53 with whichever positivity cutoff point was taken. Expression of p53 was not related to the expression of any immunohistochemical markers studied. Expression of p16 and Ki-67 was significantly associated with ProEx C expression ( Table 3) .
Relationship of HPV Genotypes to Histologic Diagnoses
The HPV genome was found in 90.1% of cases. HPV-16 was the most frequent genotype and was present in 41.1% of the infections. Other genotypes seen in order of decreasing related to the immunostaining cell-layer level: 1+, 3 (43%); 2+, 35 (88%); and 3+, 35 (100%) (P < .05).
Relationship in the Expression of Immunohistochemical Markers
As shown in ❚Table 3❚, p16 expression was significantly associated with that of cyclin D1, Ki-67, and ProEx C (P < .05). Cyclin D1 expression did not relate to that of Ki-67 but was significantly associated with that of ProEx C (P = .006). When 1+ cyclin D1 expression was considered as negative, expression of Ki-67 and ProEx C was significantly associated stained single cells was seen in 7 (50%) of 14 cases; these cases were considered negative (Image 3A, inset). Cyclin D1 expression was seen in 12 (86%) of the 14 lesions (Table 2) , in all cases restricted to the lower third of the epithelium and showing a diffuse pattern and nuclear predominant localization. Normal epithelium adjacent to AIM showed pb+ cyclin D1 expression ❚Image 3B❚. Ki-67 and ProEx C expression distribution and staining patterns were identical. Of the AIMs, 3 (21%) were positive for both markers, with expression confined to the lower third of the epithelium (1+); a focal pattern was seen in 2 (67%) of 3 of these lesions. Of 11 negative cases, 9 displayed pb+ distribution for Ki-67 and ProEx C. Normal adjacent epithelium showed a more continuous staining pattern than that seen in AIM cases ❚Image 3C❚ and ❚Image 3E❚. p53 was positive in only 1 case (7%) with 1+ distribution and a focal pattern ❚Image 3D❚. HPV was detected in 12 (86%) of AIM cases. The most frequent genotypes were HPV-16 (9 [64%]) followed by HPV-58, HPV-45, and HPV-31. Cases of AIM positive for ProEx C were positive for HPV-16 as well.
Discussion
Cell cycle deregulation has a pivotal role in cervical cancer carcinogenesis. The number of disrupted molecules involved in unscheduled proliferation is far beyond p53 and pRb, which are the targets of E6 and E7 viral oncoproteins, respectively. Therefore, the study of cell cycle regulators may be an interesting topic that may shed light on the understanding of HPV-mediated cervical carcinogenesis. Cell cycle-related immunohistochemical markers can provide pathologists with useful tools for identifying precursor lesions of cervical cancer given the increasing number of cervical biopsies carried out along the guidelines recommended by the Bethesda 2001 Workshop and the American Society for Colposcopy and Cervical Pathology. In this work, we studied frequency were HPV-58, HPV-33, and HPV-31. HPV-18 was found in only 1 case. The HPV genome was detected in 25 (93%) of 25 N/B cases, 18 (95%) of 19 LSIL cases, 81 (89%) of 91 HSIL cases, and 5 (100%) of 5 carcinomas (P > .05). In the group of HPV+ cases, the presence of HPV-16 was detected in 4 (15%) of 27 N/B cases, 7 (37%) of 19 LSIL cases, and 40 (44%) of 91 HSIL cases (P = .07; Table 2 ). When grouping LSIL and HSIL together, a significant association was found with HPV-16 (P < .05). A similar association was observed when grouping N/B and LSIL (P < .05).
The HPV-58 genome was found in 12 (44%) of 27 N/B cases, 5 (26%) of 19 LSIL cases, and 21 (23%) of 91 HSIL cases. HPV-58 presence was significantly associated with N/B and LSIL cases. (P = .02). No relationship was found between HPV-31 or HPV-33 and histologic diagnoses (P > .05; Table 2 ).
Relationship of HPV Genotypes to Immunohistochemical Findings
Positive expression of Ki-67 and ProEx C and negative expression of p53 seem to be associated with HPV-16 infection (P = .013, P = .04, and P = .04, respectively). This relationship seems to be less consistent with p16+ immunostaining (P = .09). On the other hand, no relationship was observed between cyclin D1 expression and HPV-16 infection (P > .05). Only when considering 1+ cyclin D1 expression as negative was an almost significant association found between cyclin D1 negativity and infection by HPV-33 (P = .058). HPV-58 infection was found to be inversely related to p16, cyclin D1, and ProEx C expression (P < .05, P = .07, and P = .045, respectively). No other associations were observed between HPV-58, HPV-33, and HPV-31 and immunohistochemical markers (P > .05; Table 3 ).
HPV Genotype and Immunohistochemical Patterns in AIM
p16+ immunostaining was observed in 1 of 14 AIM cases studied ❚Image 3A❚. A staining pattern consisting of faintly of p16 has been associated with progression in the colorectal adenoma-carcinoma sequence and accelerated progression in breast cancer, 25, 26 further studies will be needed to confirm this association with a higher grade of lesion in cervical neoplasia. The relationship between cyclin D1 expression and an increasing degree of dysplasia was not as remarkable as that seen for p16 but was statistically significant. Previous studies have conflicting results. Our results are in agreement with those of Bahnassy et al, 27 Nichols et al, 28 and Cheung et al. 29 Reports on the reduced expression of cyclin D1 in cases of HSIL compared with normal cervix are rare. 5, 8 However, in both of these studies, 5, 8 an increase in cyclin D1 expression was observed from CIN 3 to invasive carcinoma, which means that to find higher expression in N/B or LSIL cases compared with HSIL cases would be unlikely. The inability of overexpressed p16 to inactivate Cdk4/6, the partner of cyclin D1, may lend support to a molecular basis for the increased immunohistochemical expression of cyclin D1 in cervical cancer progression. In this study, a considerable proportion of the N/B cases showed cyclin D1 expression, but this was restricted to the lower third layer. Therefore, it seems that normal or benign epithelium retains some degree of cyclin D1 expression in this cell layer, suggesting that evaluation of abnormal cyclin D1 must be considered only when expression occurs beyond this level. When this is taken into account, the relationship between cyclin D1 expression and diagnosis becomes statistically significant.
In this study, we also observed a significant increase in the cytoplasmic staining associated with an increasing degree of dysplasia (Images 2C and 2D). This observation agrees with the report by Carreras et al. 30 Moreover, taking into account the dynamic behavior of CIN, in the series, we observed that when cyclin D1 is expressed beyond the lower third of the epithelium, cytoplasmic staining is more noticeable in the basal and parabasal layers, suggesting a recently acquired alteration directly related to a high-grade dysplasia phenotype and the progression of the disease. Possible explanations for this transition from nuclear to cytoplasmic cyclin D1 localization have been provided by Carreras et al 30 and by Baldin et al. 31 Briefly, cyclin D1 is located in the nucleus in the G 1 phase; thereafter, it undergoes phosphorylation and ubiquitination and is carried to the cytoplasm in the S phase. The increase in grade of lesion is, therefore, related to the number of cells in the S phase when cyclin D1 is located in the cytoplasm. This finding gives support to the cytoplasmic expression of p16 in lesions of higher grade since p16 is the inhibitor partner of cyclin D1 and they often appear together. 25 In this study, Ki-67 expression showed a tendency to correlate positively with histologic grade. The same correlation is often reported in the literature. 6, 7, 23, 27 However, owing to its high expression even in normal tissues, Ki-67 is not as specific as p16 in the identification of precancerous lesions. the immunohistochemical expression of 5 antibodies routinely used for diagnostic purposes in our pathology laboratory: p16, cyclin D1, Ki-67, p53, and ProEx C. We also studied the relationship among their patterns of expression and their relationship to histologic diagnoses and HPV genotypes in a series of patients with precursor lesions of cervical carcinoma.
Considering the number of cases, the number of immunohistochemical markers, and the possible introduction of artifactual variations on the immunostaining process, we decided to undertake this study using a TMA platform. Although SILs are microscopic lesions, several investigators support the theory that SILs are suitable for TMA studies. 3, 12, 21, 24 Owing to the minute amount of tissue included in each core of the arrays, each TMA has to meet 3 requirements to be eligible for evaluation. First, a significant percentage of cores must be suitable for evaluation; second, the histologic diagnosis of each core must be concordant with that of the original histologic section; and third, there must be concordance between the histologic diagnoses of the 2 cores taken from each paraffin block (peer cores). These considerations have not always been observed in previous works. 3, 24 In our study, more than 88% of cases were suitable for evaluation; the remaining cases were rejected because of stripping of the epithelial lining or because of the exclusive presence of stroma and/or endocervical glands. This percentage is consistent with that reported by others who found optimal material for evaluation in 82% of cases. 21 In our TMAs, all cores suitable for assessment produced the same histologic diagnoses as those performed in the original histologic sections. In a double-blinded histologic review, good concordance was reached between the 2 pathologists (85.7% κ coefficient). Immunohistochemical evaluation for p16, cyclin D1, Ki-67, p53, and ProEx C could be performed in only 88.0% (132/150), 90.7% (136/150), 88.0% (132/150), 90.7% (136/150), and 82.7% (124/150) of cases, respectively, mainly because cores had been used up in serial sectioning. Sample variability between the 2 cores belonging to the same specimen was estimated by the McNemar index, which revealed that this variability was 16% or less both for histologic diagnoses and for positive or negative expression of all immunohistochemical markers. All of these data suggest that our TMAs are suitable for histologic and immunohistochemical study.
The immunohistochemical expression of p16 is considered a useful marker for the identification of HPV-mediated premalignant and malignant lesions of the uterine cervix. 4 In the present work, expression of p16 was linearly and significantly associated with the degree of dysplasia, as also reported by others. 4, 8 In our study, cytoplasmic predominant localization of p16 seems to be related to the increasing cell-layer level of staining and the histologic grade of cervical lesion, although this association did not reach statistical significance (Images 2A and 2B). Although a cytoplasmic overexpression pattern reported this association as statistically significant. 15, 17, 34 Our results indicate that cell cycle alteration continues beyond the restriction point G 1 -S to S phase where the proteins detected by ProEx C, TOP2A and MCM2, exert their functions. A diffuse pattern, as seen with the use of Ki-67, is related to an increasing cell-layer level of expression and a higher grade of dysplasia, suggesting that as the dysplasia progresses, the percentage of proliferating cells in each epithelial layer increases. As a difference between these 2 markers, LSIL showed a higher percentage of ProEx C+ expression than Ki-67 ( 16 and Pinto et al. 17 Not surprisingly, the immunohistochemical markers that show more consistent association with histologic diagnoses (ie, p16, Ki-67, ProEx C, and cyclin D1 [when expressed above the lower third of the epithelium]) are related to one another. These results suggest that the alteration in G 1 -S phase transition, as demonstrated by aberrant expression of p16 and cyclin D1, continues in the S phase as shown by abnormal expression of Ki-67 and ProEx C. Again, the different forms of p53 dysfunction in cervical carcinogenesis may explain the lack of association of p53 with the rest of the immunohistochemical markers in this study.
HPV-16 was the most frequent genotype in our study. A high frequency of HPV-58 and a low frequency of HPV-18 have also been reported by other authors in Spain. 35 HPV-16 presence seems to be related to histologic lesions of higher grade, whereas the opposite situation is seen with infection by HPV-58, which is associated with lower grades of dysplasia. The reason for this finding may be the differential oncogenic potential of the most frequent genotypes found in our study, although all of them are high-risk HPV. In their seminal epidemiologic study, Muñoz et al 36 reported that female patients infected with HPV-16 have a 434.5-fold higher risk of developing squamous cervical cancer than HPV-patients. This risk decreases to 114.8 for genotype 58. 36 In our work, consistent results were observed when analyzing the relationship between HPV genotypes and the expression of immunohistochemical markers. HPV-16 seems to be associated with positivity to Ki-67, ProEx C, and, to a lesser extent, p16. The association between HPV-16 infection and ProEx C expression was recently reported by Conesa-Zamora et al 34 in a series of 100 cases. These findings are not surprising since Ki-67, ProEx C, and p16 are the markers that show a stronger relationship to the severity of histologic dysplasia. On the other hand, HPV-58 was inversely related to p16 and ProEx C positivity and, with less consistency, to cyclin D1. No previous works have reported these associations.
The sparse p16+ staining and the restriction of Ki-67 and ProEx C expression to the lower third of the epithelium In this context, a diffuse pattern, which is associated with the severity of the lesion, may help to distinguish N/B cases from precursor lesions of cervical carcinoma.
Our results show no significant correlation between p53 expression and histologic grade (P = .58). Conflicting results on this topic have been published: some studies showed a significant correlation of p53 expression with CIN 3 or carcinoma compared with normal cervix or LSIL, 27 whereas others showed no significant association. 32 Our results agree with the latter studies. In many human cancers, p53 is generally overexpressed as a consequence of point mutations that disrupt its transcriptional activity and cause down-regulation of proteins whose expression is induced by p53; one of these proteins is MDM2 (HDM2), which is the major effector of p53 down-regulation; therefore, point mutations in the p53 gene cause overexpression of an inactive form of the protein. However, the mechanism for p53 inactivation in cervical carcinogenesis is different: the E6 HPV oncoprotein causes p53 ubiquitination, and, subsequently, degradation of p53 occurs in the proteosome. This mechanism of p53 degradation does not exclude that some cervical carcinomas overexpressing p53 may be due to point mutations but at a lower frequency than observed in other types of tumor with p53+ staining. 27, 33 Based on our findings, overexpressed p53 does not seem to be related to HPV oncoprotein action, and its association with histologic grade may not be as consistent as in other types of tumor. In fact, opposite to Ki-67 staining, we observed a shift from a diffuse pattern to a focal pattern of p53 expression that matched the increase of histologic grade. Different types of p53 alterations, such as point mutations that cause overexpression or E6-induced degradation, which causes downregulation, may hamper the correct evaluation of p53 immunohistochemical analysis in HPV-induced cervical lesions.
Another reason for the lack of consistent association between p53 and grade of dysplasia may be the different role of HPV genotypes in altering p53. Some authors have related increased p53 expression to infection with low-risk HPV genotypes. 11 In agreement with these reports, we observed a significant increase in the detection of HPV-16 in p53-cases in comparison with p53+ cases. This result suggests that the absence of p53 immunostaining might be due to the higher capacity of HPV-16 to down-regulate p53 expression, probably via E6-induced ubiquitination, compared with other high-risk HPVs with less oncogenic potential. In this context, Hiller et al 32 reported from in vitro studies that HPV-16 E6 and HPV-18 E6 induce higher p53 degradation than other less oncogenic HPVs. All these findings suggest that the different forms of p53 dysfunction in cervical carcinogenesis could disguise the real status of p53 functionality in these lesions.
Based on the results, ProEx C immunostaining is significantly associated with an increasing cell-layer level of expression and a higher grade of dysplasia. Previous studies have interpret, and their evaluation is more reproducible. Because these markers are also expressed in the parabasal layer of N/B cases, the staining above the lower third layer and the pattern of staining (focal vs diffuse) may help to distinguish benign from malignant lesions. In this context, ProEx C+ expression seemed to be more specifically associated with SIL than Ki-67+ expression. HPV genotype data revealed that HPV-16 was more frequently detected as the severity of the cervical lesion increased and was also related to positive expression of Ki-67, ProEx C, and p16. In contrast, HPV-58 was more associated with N/B cases, with LSIL, and with p16 and negative ProEx C staining. Based on the immunohistochemical results obtained in AIM cases, it seems that this lesion is more similar to LSIL than to HSIL, suggesting limited oncogenic potential, although prolonged follow-up studies including more patients are needed to clarify this issue.
in positive cases suggest that AIMs are more similar to LSIL than to HSIL as pointed out by Duggan et al. 18 The remarkable p16 negativity found in our series may be due to overestimation of focal and faint p16 staining, as mentioned in previous works. 18, 19 This finding may be consistent with the lack of sensitivity of this marker to identify AIM lesions and with the lack of correlation of p16 positivity with high-risk HPV presence as reported by Iaconis et al. 19 Besides, heterogeneity of AIM and poorly reproducible diagnostic criteria might mislead pathologists to include another type of lesion such as HSIL with high p16 positivity.
Cyclin D1 distribution in the lower third of the epithelium was the best marker for distinguishing AIM from normal epithelium. Further evidence indicating low oncogenic potential of these lesions is the predominant nuclear staining seen for cyclin D1. To the best of our knowledge, no previous works have evaluated cyclin D1 expression in AIM. Another difference between normal epithelium and AIM was the shift from continuous to focal positivity for Ki-67 and ProEx C. HPV detection and genotyping in AIM are not extensively reported in the literature. In our series, the HPV genome was found in 86% of AIM cases, although this frequency is slightly higher than that reported by Geng et al 20 and Miyatake et al, 37 who found the HPV genome in 67% and 60% of AIM cases, respectively. The amplification and hybridization techniques used in our study might possibly increase detection sensitivity compared with amplification and sequencing or restriction fragment length polymorphism analysis as performed in the previous works. The genotype distribution found in our series reflects the high prevalence of HPV-16 (64%) in AIM as also reported by Miyatake et al, 37 who detected HPV-16 in 60% of AIM cases, with HPV-16 the only genotype found belonging to high-risk HPVs. A nonintegrated form of HPV-16 and inactive expression of E7 in AIM might be reasons for p16 negativity in most cases. 19 Although all 3 positive cases for ProEx C showed HPV-16, the association between these 2 markers cannot be established in AIM as has been demonstrated for LSIL and HSIL owing to the limited number of AIM cases included in our study.
Conclusions
We can conclude that p16, cyclin D1, Ki-67, p53, and ProEx C cell cycle proteins are aberrantly expressed in the LSIL-HSIL-carcinoma sequence, with p16, ProEx C, and cyclin D1 demonstrating significant association with the severity of the histologic lesion. Cytoplasmic localization of cyclin D1 is useful for identifying higher grade lesions, whereas this is not the case with p16, even though a slight relationship is observed. Markers such as Ki-67 and ProEx C, whose expression is localized exclusively in the nucleus, are easier to
